Biotechgate Global Database ›
VALNEVA - Declaration of shares and voting rights: Interim status at October 4, 2022 (and information at September 30, 2022)
VALNEVA
Declaration of shares and voting rights
Interim status at October 4, 2022 (and information at September 30, 2022)
__________________________________________________________________________________________
Company name: VALNEVA
Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)
Regulated market of Euronext Paris - Compartment A
Declaration date: October 7, 2022
Interim status at October 4, 2022
| Number of shares composing the share capital of Valneva | Total number of voting rights including suspended voting rights* | Description of the change | Date on which this change was recognized | Total number of voting rights excluding suspended voting rights** |
| 138,351,857 including:
| 160,905,006 | Capital increase without preferential subscription rights (21,000,000 new ordinary shares issued) | October 4, 2022i | 160,780,684 |
i Management Board decisions of September 29, 2022. Clearance and settlement on October 4, 2022.
Information at September 30, 2022
| Number of shares composing the share capital of Valneva | Total number of voting rights including suspended voting rights* | Description of the change | Date on which this change was recognized | Total number of voting rights excluding suspended voting rights** |
| 117,351,857 including:
| 139,905,006 | Sale of 1,101 shares with double voting rights Double voting rights granted on 65 ordinary shares | September 7 & 12, 2022 September 18, 2022 | 139,780,684 |
___________________________
* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.
** Net (or exercisable at a General Meeting) voting rights.
Attachment
Partners
Upcoming Life Sciences Events
- March 2023
- Zurich: Swiss Nordic Bio 2023
- April 2023
- Basel: Swiss Biotech Day 2023
- London: BioTrinity 2023
Latest company news
Resolutions from the Annual General Meeting of Novo Nordisk A/S
